‘Godzilla’ of weight-loss drugs could provide other important health benefits
While other drugs primarily suppress appetite or control blood sugar levels, retatrutide also engages the glucagon receptor, which helps increase energy expenditure. Photograph: Gareth Fuller/PAView image in fullscreenWhile other drugs primarily suppress appetite or control blood sugar levels, retatrutide also engages the glucagon receptor, which helps increase energy expenditure. Those in the placebo group lost 5.1%.Among those on the 12 mg dose, almost half (47%) shed at least 20% of their starting weight and almost a third (31%) lost at least 25%.
- ▪While other drugs primarily suppress appetite or control blood sugar levels, retatrutide also engages the glucagon receptor, which helps increase energy expenditure.
- ▪Photograph: Gareth Fuller/PAView image in fullscreenWhile other drugs primarily suppress appetite or control blood sugar levels, retatrutide also engages the glucagon receptor, which helps increase energy expenditure.
- ▪Those in the placebo group lost 5.1%.Among those on the 12 mg dose, almost half (47%) shed at least 20% of their starting weight and almost a third (31%) lost at least 25%.
The Guardian — Science publishes from United Kingdom and files mainly under science. We currently carry 116 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | The Guardian — Science |
| Canonical URL | https://www.theguardian.com/science/2026/sep/29/retatrutide-godzilla-of-weight-loss-drugs-other-health-benefits |
| Publication time | Tue, 29 Sep 2026 22:01:02 GMT |
| Retrieval time | 2026-09-29T22:12:33.673Z |
| Last seen | 2026-09-29T22:12:33.673Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | CxMqncNk4C9C · 1 stories |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
While other drugs primarily suppress appetite or control blood sugar levels, retatrutide also engages the glucagon receptor, which helps increase energy expenditure. Photograph: Gareth Fuller/PAView image in fullscreenWhile other drugs primarily suppress appetite or control blood sugar levels, retatrutide also engages the glucagon receptor, which helps increase energy expenditure. Photograph: Gareth Fuller/PAWeight-loss drugs‘Godzilla’ of weight-loss drugs could provide other important health benefitsThough not yet approved by any regulatory agency, retatrutide could help improve blood sugar levels and reduce inflammationAndrew Gregory Health editorTue 29 Sep 2026 18.01 EDTSharePrefer the Guardian on GoogleThe ‘Godzilla’ of weight-loss drugs could help improve blood sugar levels, reduce…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Guardian — Science.
Discussion
0 commentsMore from The Guardian — Science
